Showing results (11-20 of 236) with videos related to
Sort By:
Pageof 24
Science Signaling|August 27, 2011
β(2)-Adrenergic receptor polymorphisms and signaling: Do variants influence the "memory" of receptor activation?Paul A InselClinical Pharmacology and Therapeutics|April 23, 2020
Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the EvidenceKrishna Sriram, Paul A InselThe Journal of Biological Chemistry|May 17, 2013
Hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set point for fibrotic activity of cardiac fibroblastsDavid Lu, Paul A InselExpert Opinion on Therapeutic Targets|May 8, 2013
Targeting cAMP in chronic lymphocytic leukemia: a pathway-dependent approach for the treatment of leukemia and lymphomaFiona Murray, Paul A InselAcademic Medicine : Journal of the Association of American Medical Colleges|May 28, 2013
Preparing MD-PhD students for clinical rotations: navigating the interface between PhD and MD trainingCharles Goldberg, Paul A InselPurinergic Signalling|April 25, 2012
New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptorsRoss Corriden, Paul A InselBritish Journal of Pharmacology|July 9, 2020
Proteinase-activated receptor 1: A target for repurposing in the treatment of COVID-19?Krishna Sriram, Paul A InselPhysiological Reviews|October 30, 2020
Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targetsKrishna Sriram, Paul A InselAmerican Journal of Physiology. Cell Physiology|December 20, 2013
Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosisDavid Lu, Paul A InselBritish Journal of Pharmacology|April 26, 2020
A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalanceKrishna Sriram, Paul A InselPageof 24